These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16246553)

  • 1. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
    Yin Z; Patel SJ; Wang WL; Wang G; Chan WL; Rao KR; Alam J; Jeyaraj DA; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
    Bioorg Med Chem Lett; 2006 Jan; 16(1):36-9. PubMed ID: 16246553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
    Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Knox JE; Ma NL; Ehrhardt C; Lim SP; Vasudevan SG; Keller TH
    Bioorg Med Chem Lett; 2006 Jan; 16(1):40-3. PubMed ID: 16246563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
    Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
    Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH; Yon C; Ganesh VK; Padmanabhan R
    Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM; Judge K; DeLucas L; Padmanabhan R
    J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
    J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
    Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
    Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based mutational analysis of the NS3 helicase from dengue virus.
    Sampath A; Xu T; Chao A; Luo D; Lescar J; Vasudevan SG
    J Virol; 2006 Jul; 80(13):6686-90. PubMed ID: 16775356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the origin of the slow-binding inhibition of HCV NS3 serine protease by a novel substrate based inhibitor.
    Liu Y; Saldivar A; Bess J; Solomon L; Chen CM; Tripathi R; Barrett L; Richardson PL; Molla A; Kohlbrenner W; Kati W
    Biochemistry; 2003 Jul; 42(29):8862-9. PubMed ID: 12873147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H; Teramoto T; Padmanabhan R
    Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
    Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
    J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).
    Borowski P; Heising MV; Miranda IB; Liao CL; Choe J; Baier A
    Biochem Pharmacol; 2008 Jul; 76(1):28-38. PubMed ID: 18479669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor Bound Dengue NS2B-NS3pro Reveals Multiple Dynamic Binding Modes.
    Gibbs AC; Steele R; Liu G; Tounge BA; Montelione GT
    Biochemistry; 2018 Mar; 57(10):1591-1602. PubMed ID: 29447443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
    Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
    Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational discovery of dengue type 2 non-competitive inhibitors.
    Heh CH; Othman R; Buckle MJ; Sharifuddin Y; Yusof R; Rahman NA
    Chem Biol Drug Des; 2013 Jul; 82(1):1-11. PubMed ID: 23421589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.
    Lei J; Hansen G; Nitsche C; Klein CD; Zhang L; Hilgenfeld R
    Science; 2016 Jul; 353(6298):503-5. PubMed ID: 27386922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates.
    Gouvea IE; Izidoro MA; Judice WA; Cezari MH; Caliendo G; Santagada V; dos Santos CN; Queiroz MH; Juliano MA; Young PR; Fairlie DP; Juliano L
    Arch Biochem Biophys; 2007 Jan; 457(2):187-96. PubMed ID: 17184724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.